Search Results - "Domingo‐Musibay, Evidio"

Sentinel lymph node tumour burden using digital cell count estimation predicts outcomes in melanoma by Hartsough, Emily M, Miller, Daniel, Shanley, Ryan, Domingo‐Musibay, Evidio, Giubellino, Alessio

“…Background and aims Cutaneous melanoma often metastasises in primis to sentinel lymph nodes (SLNs). Currently, there is no standardized method of…”
Get full text

A functional variant in the immune signalling receptor NKG2D alters skin cancer risk by Vineretsky, Karin A., Domingo‐Musibay, Evidio, Karagas, Margaret R., Lazovich, DeAnn, Kuriger‐Laber, Jacquelyn K., Hunter‐Schlichting, DeVon, Nelson, Heather H.

Get full text

Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients by Özütemiz, Can, Krystosek, Luke A., Church, An L., Chauhan, Anil, Ellermann, Jutta M., Domingo-Musibay, Evidio, Steinberger, Daniel

Get full text

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma by Sarnaik, Amod A, Hamid, Omid, Khushalani, Nikhil I, Lewis, Karl D, Medina, Theresa, Kluger, Harriet M, Thomas, Sajeve S, Domingo-Musibay, Evidio, Pavlick, Anna C, Whitman, Eric D, Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D, Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S, Larkin, James M G, Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M, Chesney, Jason A

“…Effective treatment options are limited for patients with advanced (metastatic or unresectable) melanoma who progress after immune checkpoint inhibitors and…”
Get full text

A 64-Year-Old Man With Progressive Dyspnea and Cough Productive of Copious Amounts of Clear Sputum by Kloesel, Benjamin, MD, Musibay, Evidio Domingo, MD, Pedersen, Katrina, MD, Orfali, Nina, MBBCh, BAO, Mattingley, Jennifer, MD, Vassallo, Robert, MD, FCCP

Get full text

Oncolytic measles virus strains as novel anticancer agents by Msaouel, Pavlos, Opyrchal, Mateusz, Domingo Musibay, Evidio, Galanis, Evanthia

“…Replication-competent oncolytic measles virus (MV) strains preferentially infect and destroy a wide variety of cancer tissues. Clinical translation of…”
Get more information

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study by Chesney, Jason, Lewis, Karl D, Kluger, Harriet, Hamid, Omid, Whitman, Eric, Thomas, Sajeve, Wermke, Martin, Cusnir, Mike, Domingo-Musibay, Evidio, Phan, Giao Q, Kirkwood, John M, Hassel, Jessica C, Orloff, Marlana, Larkin, James, Weber, Jeffrey, Furness, Andrew J S, Khushalani, Nikhil I, Medina, Theresa, Egger, Michael E, Graf Finckenstein, Friedrich, Jagasia, Madan, Hari, Parameswaran, Sulur, Giri, Shi, Wen, Wu, Xiao, Sarnaik, Amod

“…Patients with advanced melanoma have limited treatment options after progression on immune checkpoint inhibitors (ICI). Lifileucel, a one-time autologous…”
Get full text

Stereotactic Laser Ablation (SLA) followed by consolidation stereotactic radiosurgery (cSRS) as treatment for brain metastasis that recurred locally after initial radiosurgery (BMRS): a multi-institutional experience by Peña Pino, Isabela, Ma, Jun, Hori, Yusuke S., Fomchenko, Elena, Dusenbery, Kathryn, Reynolds, Margaret, Wilke, Christopher, Yuan, Jianling, Srinivasan, Ethan, Grabowski, Matthew, Fecci, Peter, Domingo-Musibay, Evidio, Fujioka, Naomi, Barnett, Gene H., Chang, Veronica, Mohammadi, Alireza M., Chen, Clark C.

“…Introduction The optimal treatment paradigm for brain metastasis that recurs locally after initial radiosurgery remains an area of active investigation. Here,…”
Get full text

Radiation and systemic immunotherapy for metastatic uveal melanoma: a clinical retrospective review by Tran, Danielle H, Shanley, Ryan, Giubellino, Alessio, Tang, Peter H, Koozekanani, Dara D, Yuan, Jianling, Dusenbery, Kathryn, Domingo-Musibay, Evidio

“…Metastatic uveal melanoma (mUM) is a difficult to treat disease. The liver is the primary site of metastasis in most patients, though uveal melanoma spreads…”
Get full text

Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial by Hieken, Tina J., Nelson, Garth D., Flotte, Thomas J., Grewal, Eric P., Chen, Jun, McWilliams, Robert R., Kottschade, Lisa A., Yang, Lu, Domingo-Musibay, Evidio, Dronca, Roxana S., Yan, Yiyi, Markovic, Svetomir N., Dimou, Anastasios, Montane, Heather N., Erskine, Courtney L., Piltin, Mara A., Price, Daniel L., Khariwala, Samir S., Hui, Jane, Strand, Carrie A., Harrington, Susan M., Suman, Vera J., Dong, Haidong, Block, Matthew S.

“…Both targeted therapies and immunotherapies provide benefit in resected Stage III melanoma. We hypothesized that the combination of targeted and immunotherapy…”
Get full text

Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma by Domingo‐Musibay, Evidio, Heun, James M., Nevala, Wendy K., Callstrom, Matthew, Atwell, Thomas, Galanis, Evanthia, Erickson, Lori A., Markovic, Svetomir N.

“…Lessons Learned Percutaneous thermal ablation combined with in situ granulocyte‐macrophage colony‐stimulating factor cytokine therapy was technically feasible…”
Get full text

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma by Domingo-Musibay, Evidio, Murugan, Paari, Giubellino, Alessio, Sharma, Sandeep, Steinberger, Daniel, Yuan, Jianling, Hunt, Matthew A, Lou, Emil, Miller, Jeffrey S

“…Sebaceous carcinoma is an aggressive adnexal skin tumor with a predilection for the eyelids and sebaceous glands of the head and neck. A 73 year-old man…”
Get full text

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases by In, Gino K., Ribeiro, Jennifer R., Yin, Jun, Xiu, Joanne, Bustos, Matias A., Ito, Fumito, Chow, Frances, Zada, Gabriel, Hwang, Lindsay, Salama, April K. S., Park, Soo J., Moser, Justin C., Darabi, Sourat, Domingo-Musibay, Evidio, Ascierto, Maria L., Margolin, Kim, Lutzky, Jose, Gibney, Geoffrey T., Atkins, Michael B., Izar, Benjamin, Hoon, Dave S. B., VanderWalde, Ari M.

“…Melanoma brain metastases (MBM) are clinically challenging to treat and exhibit variable responses to immune checkpoint therapies. Prior research suggests that…”
Get full text

776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study by Medina, Theresa, Chesney, Jason A, Whitman, Eric, Kluger, Harriet, Thomas, Sajeve, Sarnaik, Amod A, Kirkwood, John M, Larkin, James, Weber, Jeffrey, Hamid, Omid, Wermke, Martin, Finckenstein, Friedrich Graf, Chou, Jeffrey, Gastman, Brian, Sulur, Giri, Wu, Xiao, Shi, Wen, Domingo-Musibay, Evidio

“…BackgroundImmune checkpoint inhibitors (ICI) have improved outcomes for patients with metastatic melanoma; nevertheless, resistance is common and subsequent…”
Get full text

544 DELTA-1: A global, multicenter phase 2 study of ITIL-168, an unrestricted autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in adult patients with advanced cutaneous melanoma by Gastman, Brian, Hamid, Omid, Corrie, Pippa, Gibney, Geoffrey, Daniels, Gregory, Chmielowski, Bartosz, Thomas, Sajeve, Domingo-Musibay, Evidio, Lawrence, Donald, Jiang, Yizhou, Kennedy, Audrey, Aycock, Jeff, Alvarez-Rodriguez, Ruben, Robbins, Paul, Gall, John Le, Roberts, Zachary, Hawkins, Robert, Sarnaik, Amod

“…BackgroundPatients with advanced cutaneous melanoma and persistent disease after checkpoint inhibitor therapy have poor outcomes and limited treatment options,…”
Get full text

368 REVEAL: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: local innate immune activation and systemic adaptive immune expansion for treating solid tumors by Diab, Adi, Curti, Brendan, Bilen, Mehmet, Brohl, Andrew, Domingo-Musibay, Evidio, Borazanci, Erkut, Fanton, Christie, Haglund, Cat, Vimal, Mona, Muhsin, Mann, Marcondes, Mario, Nguyen, Anh, Tagliaferri, Mary, Lin, Wei, Zalevsky, Jonathan, D’Angelo, Sandra

“…BackgroundNKTR-262 is a small-molecule agonist of toll-like receptors (TLR) 7/8. Given by intratumoral (IT) injection, NKTR-262 is retained within the tumor…”
Get full text

What next for newly diagnosed glioblastoma? by Domingo-Musibay, Evidio, Galanis, Evanthia

“…Glioblastoma is the most common primary brain tumor in adults. Despite current multimodality treatment including surgical resection and temozolomide-based…”
Get full text

Gene and virotherapy for hematological malignancies by Domingo-Musibay, Evidio, Yamamoto, Masato

“…Recent years have seen a transformation in the treatment of hematological malignancies. Advances in gene therapy and molecular techniques and significant gains…”
Get full text

Propranolol: What is BLOCKing Its Clinical Investigation in Breast Cancer? by Blaes, Anne H, Domingo-Musibay, Evidio, Kalinsky, Kevin

“…Presurgical propranolol modulates biomarkers associated with breast cancer progression. β-adrenergic signaling promotes invasion, epithelial-to-mesenchymal…”
Get full text

Gene- and Viro- therapy for Hematological Malignancies by Domingo-Musibay, Evidio, Yamamoto, Masato

“…Treatment of the hematological malignancies has undergone recent transformation. Advances in gene therapy and molecular techniques, as well as significant…”
Get full text